Mirum Pharmaceuticals, Inc. Balance Sheet

Balance Sheet Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Assets
Assets 240.86M294.65M352.91M646.62M670.75M
Current Assets
Cash & Equivalents 142.09M131.34M128.00M286.33M222.50M
Short-term Investments 89.73M125.20M123.72M57.81M
Cash & Current Investments 231.82M256.54M251.72M286.33M280.31M
Receivables - Net 3.27M23.99M67.97M78.29M
Receivables 3.27M23.99M67.97M78.29M
Raw Materials 0.86M3.00M3.03M
Work In Process 0.57M5.35M9.87M16.09M
Finished Goods 0.09M0.21M9.44M3.28M
Inventory 1.51M5.57M22.31M22.40M
Prepaid Assets 4.53M5.27M8.95M10.94M11.78M
Current Assets 236.35M166.59M190.22M387.54M392.79M
Non-Current Assets
Property, Plant & Equipment (Net) 1.29M0.98M0.91M0.71M1.14M
Long-Term Investments 4.98M12.53M
Intangibles 18.74M58.95M252.93M249.82M
Goodwill & Intangibles 18.74M58.95M252.93M249.82M
Other Non-Current Assets 1.27M1.79M1.38M4.17M5.38M
Non-Current Assets 4.51M128.06M162.68M259.08M277.97M
Liabilities
Current Liabilities
Accounts Payables 3.15M9.17M8.69M7.42M14.62M
Payables 3.15M9.17M8.69M7.42M14.62M
Accumulated Expenses 13.41M30.72M54.02M78.54M111.93M
Short term Debt 1.26M2.00M1.09M
Current Leases 0.64M0.71M0.93M1.10M1.71M
Total Current Liabilities 18.46M42.60M64.73M87.06M126.55M
Non-Current Liabilities
Convertible Debt 306.42M308.08M
Operating Leases 2.63M1.90M1.26M0.62M7.97M
Other Non-Current Liabilities 47.65M129.92M140.35M3.85M2.51M
Total Non-Current Liabilities 21.12M44.52M70.52M394.10M442.61M
Liabilities
Total Liabilities 68.77M174.44M210.87M397.95M445.11M
Shareholder's Equity
Total Debt 1.26M2.00M1.09M
Common Equity 172.09M120.21M142.04M248.67M225.64M
Shareholder's Equity 172.09M120.21M142.04M248.67M225.64M
Liabilities and Shareholders Equity 240.86M294.65M352.91M646.62M670.75M
Retained Earnings -173.17M-257.16M-392.82M-556.24M-644.18M
Treasury Shares 0.26M0.12M0.15M0.28M